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Abstract: Fibrocellular membrane or epiretinal membrane (ERM) forms on the surface of the inner
limiting membrane (ILM) in the inner retina and alters the structure and function of the retina.
ERM formation is frequently observed in ocular inflammatory conditions, such as proliferative
diabetic retinopathy (PDR) and retinal detachment (RD). Although peeling of the ERM is used as a
surgical intervention, it can inadvertently distort the retina. Our goal is to design alternative strategies
to tackle ERMs. As a first step, we sought to determine the composition of the ERMs by identifying
the constituent cell-types and gene expression signature in patient samples. Using ultrastructural
microscopy and immunofluorescence analyses, we found activated microglia, astrocytes, and Müller
glia in the ERMs from PDR and RD patients. Moreover, oxidative stress and inflammation associated
gene expression was significantly higher in the RD and PDR membranes as compared to the macular
hole samples, which are not associated with inflammation. We specifically detected differential
expression of hypoxia inducible factor 1-α (HIF1-α), proinflammatory cytokines, and Notch, Wnt,
and ERK signaling pathway-associated genes in the RD and PDR samples. Taken together, our results
provide new information to potentially develop methods to tackle ERM formation.
Keywords: human retina; epiretinal membrane; internal limiting membrane; vitreoretinal surgery;
macular hole; proliferative diabetic retinopathy
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1. Introduction
The retina is a multilayered light-sensing neural tissue located at the back of the eye [1]. The outer
retina is composed of photoreceptors, which convert light into electrical signals and transmit them to
the inner neurons and to the ganglion cells in the inner retina. The ganglion cell layer is also composed
of Muller glia, whose foot processes are embedded into a thin transparent layer in the basal lamina of
the inner retina called the inner limiting membrane (ILM). The ILM forms a boundary between the
retina and the underlying vitreous [2–4].
Epiretinal membrane (ERM), a fibrocellular tissues forms on the surface of ILM, mainly on the
macula. ERMs can be either: (a) idiopathic or (b) associated with ocular inflammatory diseases such as
diabetic retinopathy and retinal detachment [5,6]. ERMs distort the underlying ILM and alter retinal
morphology and function. Survival and proliferation of the cells present on the ERM also depends
upon the oxygen level. Ischemic conditions lead to accumulation/activation of the transcription factor,
hypoxia-inducible factor (HIF-1α), which causes secretion of vasoactive cytokines vascular leakage
and macular edema [7]. Growth factors such as hepatocyte growth factor (HGF), heparin-binding
epidermal growth factor (HB-EGF), and epidermal growth factor (EGF) others and other inflammatory
molecules released due to any retinal insults also induce the migration of retinal cells like RPE to the
vitreous to proliferate and induce the retinal membrane formation.
Currently, ILM removal along with ERM peeling is considered the gold standard treatment and
results in minimal recurrence of the ERMs. However, the extent of successful restoration of vision
varies as ERM peel can lead to retinal breaks and perturb outer retina function. Therefore, ILM peeling
requires a decision on the inevitability of ERM removal only for selected needful patients.
We propose that understanding the cellular composition and gene expression signature of the
ERMs will assist in designing strategies to tackle ERM formation with minimal effects on the ILM or
avoid ERM peeling in patient where it may play a beneficial role, such as in preventing macular hole
formation [8,9]. Previous remarkable studies have identified hyalocytes, glial cells, retinal pigment
epithelial cells, fibrocytes and myofibroblast along with non-cellular component like fibronectin,
and actin [10,11]. However, a comprehensive analysis of the different components and a gene
expression profile related to oxidative stress and pro-inflammatory signaling associated genes have
not been investigated.
In the present study, we carried out a comparative histological, ultrastructural and gene
expression analysis of fibrocellular membranes associated with inflammatory conditions of the
eye. Our results expand our understanding on the role of activated microglia in ERMs and suggest
that immunomodulation by targeting microglia could be a potential therapy for a better clinical
management of the condition.
2. Materials and Methods
2.1. Enrollment of Subjects
Initially, ILM specimens (n = 30) were collected during vitreo-retinal surgery from June 2016
to September 2017 at the L.V. Prasad Eye Institute by a single vitreoretinal surgeon (Jay Chhablani)
and were used for Hematoxylin and Eosin (H&E), transmission electron microscopy (TEM) and
immunohistochemistry (IHC)-based evaluations. Additional membranes (n = 15, 3 in MH, 8 in PDR
and 4 in RD) were collected from the additional ORs of two other vitreo-retinal surgeons (Mudit Tyagi
and Rajeev Reddy Pappuru) for the targeted gene expression profiling. This prospective study was
approved (Ethic Ref No. LEC 02-14-029) by the Institutional Review Board (IRB) of L.V. Prasad Eye
Institute, Hyderabad, India (LVPEI) and adhered to the tests of the Declaration of Helsinki. A prior
informed consent was obtained from each study subject. All subjects underwent a comprehensive
ophthalmic examination with Snellen’s visual acuity, slit lamp examination, intraocular pressure
measurement using applanation tonometry and dilated fundus examination. All eyes except eyes
with RRD underwent preoperative spectral domain optical coherence tomography (OCT) Cirrus
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High Definition-OCT (Carl Zeiss Meditec, Dublin, CA, USA). Five-line high definition raster scan
was performed.
The membranes removed as part of the routine surgical management were collected from different
pathological conditions. Subjects with the diagnosis of vitreoretinal interface disorders including
idiopathic macular hole (MH), proliferative diabetic retinopathy (PDR) and rhegmatogenous retinal
detachment (RD) who underwent pars plana vitrectomy (PPV) with Brilliant blue-G (BBG)—assisted
inner limiting membrane peeling (ILM peeling) were included in the study.
2.2. Surgical Details
Surgical procedure included 23- or 25-gauge vitrectomy. After induction of posterior vitreous
detachment, vitrectomy was completed. Epiretinal membranes were removed using end-gripping
forceps. For ILM staining, 0.02% brilliant blue was used under air infusion. After one minute of
staining, ILM at the macular area was removed using ILM forceps. In eyes undergoing macular
hole repair, C3F8 gas (12–15%) was used as tamponade. Cataract surgery was performed during the
follow-up in cases where it was needed with standard phacoemulsification procedure, and posterior
chamber intraocular lens was implanted. In cases with rhematogenous RD, brilliant blue staining of
ILM was performed under fluid with infusion canula off.
2.3. Histopathological Investigation
All surgically peeled membrane samples were embedded in the optimal cutting temperature
compound (OCT)-medium (Leica Biosystems, Nussloch GmbH, Germany) and stored at−20 ◦C initially
for slow freezing. After freezing, sections of 4 µm thickness were prepared using cryostat (Leica
CM1950 Clinical Cryostat-Leica Biosystems, Nussloch GmbH, Germany) for each subject. The sections
were stained with hematoxylin and eosin (H&E) dyes and images were taken at 4× and 10×with an
inverted microscope (Olympus Corporation, Shinjuku, Tokyo, Japan).
2.4. Ultrastructural Evaluations of Membranes Using Transmission Electron Microscopy
The surgically excised membranes were stored in 3% glutaraldehyde at room temperature for
24 h followed by the standard procedures [11,12] for sample preparation. Ultra-thin (70 nm) sections
were made with a diamond knife on ultramicrotome (Leica Ultra cut UCT-GA-D/E-1/00), mounted on
gold grids and stained with saturated aqueous uranyl acetate (UA) and counter stained with Reynolds
lead citrate (LC) and viewed under TEM (Model: CM10,Philips, North Worcester, MA, USA).
2.5. Cellular Characterization Using Immunohistochemistry
The tissue sections were processed for immunohistochemistry using cell type specific primary
antibodies including rabbit anti-glial fibrillary acid protein antibody (GFAP) (glial marker, 1:400, Z0334,
Dako, Glostrup, Denmark), rabbit anti-ALDH1L1 (astrocytes, 1:500, ab190298, Abcam, Cambridge, MA,
USA), mouse anti-cellular retinaldehyde-binding protein (CRALBP) (retinal astrocytes, 1:80, ab15051,
Abcam), rat anti-F4/80 (macrophages, 1:30, ab16911, Abcam,), and rabbit anti-oxidation resistance
1 (Oxidative stress, 1:100, HPA027395,Sigma, St. Louis, MO, USA), against OXR1; a protein that
controls the resistance of neuronal cells to oxidative stress. After sectioning the slides were stored at
−20 ◦C. For the experiment, slides were taken out from the −20 ◦C and kept at room temperature for
30 min to bring them to room temperature. Next, the slides were dipped in fixative (chilled methanol:
acetone (95:5) solution) for 15 min and dired for 30 min at room temperature. The slides were then
washed three times with 1× PBS. 1% BSA (Himedia, Lab Pvt. Ltd., Mumbai, Maharashtra, India)
and incubated with blocking buffer containing 0.1%-Tween20 (Fisher Scientific, Guldensporenpark,
Merelbeke, Belgium) for 2 h. The sections were then incubated with the primary antibody overnight.
The primary antibodies were diluted in 0.1% blocking buffer. After overnight incubation, the slides
were washed three times with 1X PBS, for 5 min each, followed by secondary antibody incubation at a
dilution 1:300 (Alexa Fluor® 488 Goat Anti-Rabbit IgG, (A-11008, Invitrogen, Waltham, MA, USA)
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and Alexa Fluor® 488 Goat Anti-Mouse IgG, (ab150117, Abcam). Negative control IHC was done to
test the specificity of antibody and to identify false positive results shown in Figure S1. Details of the
antibodies are provided in Table S1.
2.6. Imaging and Image Analysis
The digital inverted microscope (EVOS FL Cell Imaging System, Life Technology, Paisley, UK)
was used for the imaging at X200 final magnification. Further, total number of cells based on DAPI
staining and the total number of positively stained cells for each marker were counted on individual
sections corresponding to different pathological conditions. Average and standard deviation of the
mean number of cells for each marker from specimens (n = 3) in different pathological conditions were
calculated. Percentage of OXR1 positive cells was calculated using: (total number of OXR1 positive
cells divided by total number of DAPI stained cells) × 100.
2.7. Targeted Gene Expression Profiling by qRT-PCR
Total RNA was isolated from membranes using PureLink™ RNA Mini Kit (Invitrogen™, catalog
no. 12183018A) following the manuals as instructed. RNA was converted to cDNA using verso cDNA
synthesis kit (Thermo Scientific™, Waltham, MA, USA, catalog no. AB1453B). A reaction mixture of
volume 10µL was made using iTaq™ Universal SYBR® Green Supermix (BIO-RAD, Hercules, CA,
USA, catalog no. 38220090), 200nM of primer and cDNA and further, subjected to Applied Biosystems
7900 HT system. A relative measurement of the concentration of target gene (CT) was calculated by
using software SDS 2.4 (Applied Biosystems, Foster City, CA, USA). Differential gene expression was
analyzed using the 2−∆∆CT method. Statistical analyses were performed using the 2−∆∆CT ± SEM.
β-actin; a housekeeping gene was used as a normalizing control. The primer sequences used for
semi-quantitative real time PCRs are given in the Table S2.
2.8. Statistical Analysis
The total number of cells were counted manually in a defined fixed quadrant and equal area of
each images. Average number of the cells were accounted for further the descriptive statistical analysis
included mean and standard deviation (SD) described in Section 2.6. t-Test was used to calculate
significance for qPCR data and mean fold changes ± SE were plotted in a graph. A p-value less than
0.05 was taken as statistically significant.
2.9. Bioinformatic Analysis
For gene expression analysis, a heat map was generated using the online tool Heatmapper (http:
//www.heatmapper.ca/expression/). Protein-protein interaction was predicted using STRING (v 11.0)
(https://www.string-db.org/). Where network edges were defined based on evidence. The minimum
required interaction score was kept at minimum confidence of 0.400, with no more than 50 interactors.
The active interaction sources were text mining, experimentally proved, database, co-expression data,
neighborhood joining, gene fusion, and co-occurrence.
3. Results
3.1. Demographical Data
The mean age (mean age ± standard deviation) of the subjects included in this study was
55.22 ± 7.35. The number of males and females were 33 and 12 respectively.
3.2. Histological Evaluations and Cellular Profiling
Histological analysis of the ERMs revealed spindle cells with round or oval hyperchromatic nuclei
(black arrow; Figure 1 and Figure S1) and pale eosinophilic cytoplasm with or without uveal pigment.
Antioxidants 2020, 9, 654 5 of 15
The cellularity varied among specimens; it was lower in macular hole samples as compared to PDR
and RD. We did not detect a significant difference in cellularity between PDR and RD samples.Antioxidants 2020, 9, x FOR PEER REVIEW 5 of 15 
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Figure 2. Transmission electron microscopy images of fibrocellular membranes from; A–C; macular 
hole, and D–E; proliferative diabetic retinopathy membrane showing the presence of astrocytes, 
Müller glia processes and microglia. The cell body of a Müller cell can be identified by its nucleus and 
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intermediate filaments (yellow colored asterisk) can be observed next to the Müller cell. The microglia 
can be seen with round shaped dark cell bodies (brown arrow) and glial cells processes with skyblue 
Figure 1. H&E staining of epiretinal membrane (A) macular hole, (B) retinal detachment,
(C) proliferative diabetic retinopathy. Photomicrographs in all except macular hole show the presence
of spindle shaped cells (black pointed arrows) and the adjacent fibro-collagenous tissue. (H&E;
scale bar = 400 µm).
3.3. Ultrastructural Characterizations
Next, we performed ultrastructural characterization by TEM of the membranes extracted from
three subjects belonging to the PDR and MH groups. The membranes from RD cases were not included
due to insufficient numbers.
The retin l cell-types wer characterized based on previously published morph logical d tails [13–18].
Varying thickness of collagen fibrils, the main component of the ERMs was observed in both PDR
and MH. We frequently detected astrocytes, Müller glia with long processes, microglia like cells with
thick dark heterochomatic cell body and a few dark pigmented cells (Figure 2) in the PDR versus the
MH specimens.
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Figure 2. Transmission electron microscopy ima f fibrocellular embranes from; (A–C); macular
hole, and (D–E); proliferative diabetic retinopathy membra e showing th presence of astrocytes,
Müller glia processes and microglia. The cell body of a Müller cell can be identified by its nucleus and
dark cytoplasm (red color filled triangular shape). An astroglial cell process with flattened intermediate
filaments (yellow colored asterisk) can be observed next to the Müller cell. The microglia can be seen
with round shaped dark cell bodies (brown arrow) and glial cells processes with skyblue star shaped
structure. (B,E) show collagenous fibrils of membrane indicated by black arrow and; (C,F) show their
corresponding magnified image.
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3.4. Characterization of Different Cell Types in Each Group
We next validated the presence of the specific cell types by indirect immunofluorescence using
appropriate marker antibodies. We used nine samples, with three samples from each group (MH, RD
and PDR). The MH samples were used as negative controls.
Our analyses confirmed the presence of both macroglial and microglial cells along with other
proliferative spindle shaped cells. While GFAP and ALDH1L1, markers for astrocytes (and gliosis)
were mostly detected in all specimens, the PDR samples showed greater number of GFAP positive cells
present in the membrane as compared to MH and RD specimens (Figure 3 and Figure S2). CRALBP
staining did not significantly differ in the Müller glia among PDR and RD samples. The number of
CD11b (microglia marker) positive cells was higher in the RD membranes as compared to the others.
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Figure 3. Repres ntative images s i g I C of membranes from pathological conditions MH, RD
and PDR with intense cytoplasmic and me branous expression of GFAP, CRALBP, and CD11b proteins.
(Scale bar; 100 µm).
Quantification of the cells present on the membrane validated the higher number of CD11b
positive cells in RD than MH and PDR. On the other hand, increased number of GFAP positive cells
was seen in PDR as compared to all cases (Table 1).
Table 1. The number of different cell types identified by immunohistochemistry using different specific
markers where GFAP; astrocytes/gliotic changes, CRALBP; Müller glia, CD11b; microglia are used.
S. No. Pathology H&E Cell Specific Marker Mean no. of PositiveCells (n = 3) ± SD
1. MH No pigmentation
GFAP 0 ± 0
CRALBP 0 ± 0
CD11b 0 ± 0
2. RD Pigmentation
GFAP 8 ± 8.4
CRALBP 19 ± 7.0
CD11b 2.5 ± 3.5
3. PDR No pigmentation
GFAP 11 ± 8.7
CRALBP 6.3 ± 6.6
CD11b 1.6 ± 1.5
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3.5. Evaluation of Oxidative Stress among Different Pathological Condition
To further explore the involvement of oxidative stress in the ERMs, we performed
immunofluorescence analysis using anti-OXR1 antibody in the same tissue specimens (n = 3) of
MH, RD and PDR cases. OXR1 is expressed at elevated levels in cells undergoing oxidative stress [19].
We found a greater number of OXR1-positive cells in the RD sample than PDR (p = 0.04) shown in
Figure 4; none of the cells was positive for OXR1 in the membranes from MH.
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3.6. Gene Expression Analysis of Oxidative Stress and Inflammation-Related Pathway Genes
Oxidative stress though being closely interlinked to inflammation, could also be the cumulative
effect of continued insults to the eye such as ischemia and hyperglycemia [20]. To further quantitate
the underlying oxidative stress and inflammation in membrane formation and DR pathogenesis,
a targeted gene expression profiling was undertaken by semi-quantitative real time PCR using SYBR
green chemistry. We used MH as control and the expression was measured among MH, PDR and
RD. Initially, to measure the underlying oxidative stress, we used Nrf2, and HIF1-α while MMP9,
and IL1-β were used as markers of inflammation. Expression of CD11b and VEGF was also measured
for activated microglia and angiogenesis. In comparison to MH, the gene expression of Nrf2, HIF1-α
and MMP9 was higher in the RD (Nrf2: 31.81 ± 0.76, *** p = 0.00066; HIF1-α: 13.423 ± 0.63, *** p = 0.005;
MMP9: 8.851 ± 0.86, * p = 0.04) followed by PDR (Nrf2: 2.76 ± 0.16, ** p = 0.007; HIF1-α: 3.88 ± 0.47, ns,
p ≥ 0.05 and; MMP9: 4.901 ± 0.86, * p = 0.03). Consistently, we noticed increased expression of IL1-β in
RD (8.648 ± 0.43, * p = 0.03) and PDR (5.282 ± 0.27, ns, p ≥ 0.05) compared to MH. VEGF, an angiogenic
marker showed almost similar elevated level of expression in both RD (2.542 ± 0.63, * p = 0.031) and
PDR (1.42 ± 0.13, * p = 0.01). Likewise, CD11b, also showed significantly higher expression in RD
(10.333 ± 0.23, *** p = 0.000076), and PDR (3.092 ± 0.25, * p = 0.011) than MH (Figure 5a).
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inflammation, the additional genes and pathway chosen for this analysis were selected based on the 
existing proposed pathogenic theories in the literature and those known to be involved in retinal 
cellular proliferation and maintenance. There was significant upregulation of NOTCH1 gene 
expression in RD (8.427 ± 0.64, ** p-value=0.008) and PDR (6.459 ± 0.81, *p-value = 0.02) as compared 
Figure 5. (a,b) Differential gene expression analysis of oxidative stress, inflam atory markers a their
associated pathway involved in the pathogenesis of epiretinal membrane of RD, PDR compared to
macular hole (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001) (c) Heat map showing the expression pattern of the
differentially expressed genes in PDR and RD.
We then analysed the expression of the genes associated with major signaling pathways including
NOTCH1, DKK1 and ERK1 in the ERMs from RD and PDR. Besides oxidative stress and inflammation,
the additional genes and pathway chosen for this analysis were selected based on the existing proposed
pathogenic theories in the literature and those known to be involved in retinal cellular proliferation
and maintenance. There was significant upregulation of NOTCH1 gene expression in RD (8.427 ± 0.64,
** p-value=0.008) and PDR (6.459 ± 0.81, * p-value = 0.02) as compared to control (MH) (Figure 5b).
Although DKK1 and ERK1 were downregulated, the effect was not statistically significant.
Further, the heatmap, a clustering based method that groups genes and/or samples together based
on the similarity of their gene expression pattern, showed the differential expression profile of the
genes for PDR and RD shown in Figure 5c. Except for NRF2 all other genes that clustered together
seems to be regulated by common processes.
To further validate the presence of activated microglial, we again performed immunofluorescence
analyses of both resting microglia and activated microglia markers: F4/80 and Iba1 respectively.
The results showed the presence of both resting as well as activated microglia in all pathologies except
MH as shown in Figure 6.
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3.7. Protein-Protein Interactions for the Differentially Expressed Genes by In-Silico Analysis
To further understand functional overlap among the significantly expressed genes in different
pathways, we performed bioinformatic analysis using STRING (v 11.0). The examined genes (HIF1-α,
Nrf2, VEGF, IL1-β, CD11b, NOTCH1, MMP9, ERK1, and DKK1) showed interaction among each
at the protein level (Figure 7a). Several other proteins were also identified that interact with the
studied proteins to modulate specific signaling pathways. Genes differentially expressed in the ERMs
of PDR and RD are also shared with the genes belonging to the innate immune system, hypoxia
related signaling, inflammatory pathways mediated by microglia, VEGF signaling, TNF-α signaling,
MAP kinase signaling and extra cellular reorganization (Table 2).
Further, functionally associated proteins involved in the disease pathogenesis were also determined
by studying their co-expression. We found MMP9, IL1-β and ITGAM (alias for CD11B) are functionally
associated and co-expressed. Similarly, HIF1-α, and Nrf2 were co-expressed together showing their
strong association in disease pathogenesis (Figure 7b).
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Table 2. List of the important pathways involved in ERM pathogenesis.
S. No. #Term ID Term Description ObservedGene Count
B ckground
Gene Count False Discovery Rate
Matching Proteins in the
Network (Labels)
1 hsa04066 HIF-1 signaling pathway 17 98 7.73 × 10−23
AKT1,ARNT,CREBBP,CUL2,EGLN1,
EGLN2,EP300,FLT1,HIF1A,HMOX1,
MAPK3,STAT3,TCEB1,TCEB2,
TIMP1,VEGFA,VHL
2 hsa04330 Notch signaling pathway 10 48 5.83 × 10−14
CREBBP,EP300,MAML1,MAML2,
MAML3,NOTCH1,NOTCH2,
NOTCH3,NOTCH4,RBPJ
3 hsa04010 MAPK signaling pathway 14 293 1.23 × 10−11
AK 1,DUSP6,FIGF,FLT1,IL1A,
IL1B,IL1R1,JUN,KDR,MAPK3,
PGF,VEGFA,VEGFB,VEGFC
4 hsa04933
AGE-RAGE signaling
pathway in
diabetic complications
10 98 2.75 × 10−11
AKT1,FIGF,IL1A,IL1B,JUN,MAPK3,
STAT3,VEGFA,VEGFB,VEGFC
5 hsa04610 Complement andcoagulation cascades 8 78 2.56 × 10
−9 C3,CD46,CD55,CFB,CFH,CFI,
CR1,ITGAM
6 hsa04060 Cytokine-cytokine receptorinteraction 11 263 7.33 × 10
−9 FIGF,FLT1,IL10,IL1A,IL1B,IL1R1,
1R2,KD ,VEGFA,VEGFB,VEGFC
7 hsa04014 Ras signaling pathway 10 228 2.3 × 10−8
AKT1,FIGF,FLT1,KDR,MAPK3,PGF,
PTPN11,VEGFA,VEGFB,VEGFC
8 hsa04668 TNF signaling pathway 6 108 6.86 × 10−6
AKT1,IL1B,JUN,MAPK3,
MMP9,VEGFC
9 hsa04151 PI3K-Akt sigpathway 9 348 6.87 × 10
−6 AKT1,FIGF,FLT1,KDR,MAPK3,PGF,
VEGFA,VEGFB,VEGFC
10 hsa04310 Wnt signaling pathway 6 143 2.51 × 10−5
CREBBP,DKK1,EP300,JUN,
LRP5,LRP6
11 hsa04630 Jak-STAT signalingpathway 6 160 4.36 × 10
−5 AKT1,CREBBP,EP300,IL10,
PTPN11,STAT3
12 hsa04370 VEGF signaling pathway 4 59 1.4 × 10−4 AKT1,KDR,MAPK3,VEGFA
4. Discussion
Here, we show that activated microglia are a major component of the ERMs from RD and
PDR patient samples. Microglial cells are involved in neurotrophic and neurodegenerative disease
mechanisms in the retina under stress conditions. In mature retina, microglia reside in the inner and
outer plexiform layers and exhibit an abundantly ramified morphology spanning the complete nuclear
layers with their long protrusions [21]. Their most important role is to maintain a constant active
surveillance of retinal homeostasis where they are indispensable for the immune response and synaptic
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pruning and transmission [22,23]. Under injury or ischemic stress, they get activated, proliferate
and migrate to the site of damage, while releasing pro-inflammatory cytokines and ROS to counter
the damage [24]. We recently demonstrated the role of microglial mediated aberrant complement
activation in the pathogenesis of DR [25]. That study showed that a gradual increase in the expression
of CFH (inhibitor of alternate complement pathway) and CD11b (activated microglial marker) in the
retina (at an early stage) culminated in epiretinal membranes changes in DR patients further supporting
for a major role of microglia and the alternative complement pathway in disease progression.
While there were not many differences in the cell types present in the membranes from different
pathologies, higher number of GFAP positive cells in PDR and RD confirmed the presence of
astrocytes and Müller glia and the glial activation (reactive gliosis). Reactive gliosis is known to cause
inflammation, which leads to neurodegeneration [26]. The presence of GFAP positive cells could be
due to phagocytosis and gliotic responses of Müller glia in the retina. Astrocytes are predominantly
localized to the subretinal space near the ILM, where they activate and proliferate during vascular
injury and neovascularization. Along with endothelial cells and pericytes, they are also involved
in the formation of epiretinal vessels under ischemic condition [27,28]. Besides Müller glia and
astrocytes, a large number of activated microglia was also detected in these membranes (RD and PDR).
The presence of these cells indicates their role in ERM formation besides underlying gliosis. Such
mechanisms may underlie the extensive gliotic changes, which pose surgical challenges.
Activated microglia secrete different types of cytokines [29]. Underlying gliosis causes the
induction of inflammation, which in turn promotes oxidative stress. This is supported by our results
of immunohistochemistry using anti-OXR1, an oxidative stress responsive gene. The fibrocellular
membranes from RD and PDR showed significantly higher number of anti-OXR1 positive cells as
compared to MH. Higher expression of CD11b along with significant increase of oxidative stress
markers (HIF1-α and Nrf2), inflammatory markers (IL1-β and MMP9) and vascular endothelial growth
factor (VEGF) in RD and PDR further suggested oxidative stress activates the resident microglia in
the retina and adopt inflammatory phenotype. The activated ramified microglia migrate and secrete
inflammatory cytokines and growth factors that promote cellular proliferation, neuronal apoptosis and
phagocytosis. Inflammatory cytokines could serve as chemoattractants for invading macrophages.
Higher expression of VEGF increases the endothelial cell permeability that would leads to further
immune cell recruitment and disease manifestation. A study on histopathological analysis of eyes
from patients with non-PDR and PDR showed increased numbers of hypertrophic microglia which
correlated with disease severity [30].
Activated microglia also express activated C3a and C3b receptors on cell surface and in turn, induce
astrocytes to adopt a reactive and proinflammatory phenotype. Such phenomena compromise the ability
of neurons to form synapses and phagocytose dead neurons in the central nervous system. Increased
deposition of dead neurons could further induce neuroinflammation and neovascularization [31].
We therefore, propose that activated microglia and astrocytes in the ERMs from RD and PDR could
result from the proinflammatory phenotype of activated astrocytes in the retina. Further studies are
needed to test this hypothesis.
In retinal pigment epithelium cells, Notch2 has been shown to be the major Notch receptor,
and its inhibition significantly reduces the intracellular ROS production and cellular apoptosis upon
ultraviolet B-induced damage. On the other hand, hypoxic stress to retinal ganglion cells induces
Notch1 expression and activation. A study by Jiao et al. 2018, examined the effects of NOX4 mediated
Notch signaling under hyperglycemic (HG) stress. The study observed that HG upregulates Nox4
expression via the activation of Notch signaling, resulting in increased ROS production and cell death
in HRECs and thus the inhibition of Notch signaling or Nox4 expression was suggested to be potential
therapeutic strategy for the treatment of DR [32].
Several theories have been suggested based on cellular evidences for the processes involved
in the membrane formation. Some studies reported that PVR exposes the retina to blood derived
fibroblast and other cytokines that causes RPE cells to undergo epithelial to mesenchymal transition
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and forming proliferative spindle like cells that initiate retinal remodelling and membrane formation
over the ILM. Epithelial to Mesenchymal Transition (EMT) facilitates the adoption of a mesenchymal
phenotype by an epithelial cell by undergoing multiple biochemical changes. The process of EMT has
been well-documented in different types of cancers, leading to tumor progression and increased tumor
invasiveness. Besides the other know mechanisms, release of inflammatory cytokines by immune
cells has also been shown to cause EMT. Recently, a link between MMP9 and NOTCH1 signalling was
also demonstrated [33]. Overexpression of MMP9 acts as a strong activator of NOTCH1 signalling.
An earlier study by our group demonstrated increased expression of MMP 9 in PDR vitreous humor that
is contributed by activated microglia. The present study also demonstrated an increased expression of
CDllb, MMP9, IL-1β and Notch in the membranes as seen by heatmap and co expression using STRING
analysis. All together these observations definitely provide a link between increased activation of
microglia with RPE undergoing EMT thereby leading to membrane formation as seen in PDR and RD
cases by activating Notch 1 signaling and thus inhibiting Notch 1/MMP9 signaling can be a potential
therapy to prevent DR severity.
Studies have shown that ERMs impair oxygen and nutrient supply to the retina under ischemic
condition [34]. It may also cause tractional retinal detachment by pulling on the neurosensory retina.
Our study demonstrated higher level of oxidative stress along with inflammation in RD. Hence,
the removal of ERMs may help in improving the oxygenation, nutrient supply and ion transport
for retinal potassium buffering [35]. Interestingly, the surgical treatment ILM peeling is found to
significantly depend on the type of ERM adherence and area where ERM attaches to the retina. ILM
peeling causes mechanical trauma to the retinal nerve fiber layer (RNFL) [36], making this procedure
controversial [37].
Our study shows overexpression of oxidative stress-related pathways genes in the fibrocellular
membranes (Figure 8). We suggest that modulating the levels of oxidative stress and inflammation in
PDR and RD could assist in predicting the need of simultaneous ERM/ILM peeling and may be helpful
in improving surgical outcomes.
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Figure 8. Schematic representation of proposed icroglial activity in the epiretinal membrane of the
retina. In healthy retina, resident microglia are involved in immune surveillance of all the layers
of the retina and maintain retinal homeostatis by synaptic pruning, regulation of neurogenesis and
axonal growth. With their phenotypic change of shape, they phagocytose cellular debris. Different
kinds of stress/insults lead to abnormal functioning of retinal neurons, microglia, astrocyte, Müller
glia and RPE cell . The resident/ esting microglia in the retina get activated by transforming into an
amoeboid shape and further interact with other neighboring retinal cells, causing abnormal functioning
and trans-differentiation into proliferative cells types [10,11]. It also induces the secretion of several
chemokines, proinflammatory cytokines and growth factors etc (results from the present study) that
could aid in membrane formation by remodeling of the extracellular matrix proteins in retina and
thereby contribute to disease pathogenesis.
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5. Conclusions and Future Scope
We have shown the involvement of microglial cells, inflammation and oxidative stress in fibrocellular
membranes (ERM/ILM) of different pathological conditions. Under oxidative stress microglia cells
get activated and interact with other glial cells and retinal cells to cause neuroinflammation and
neurodegeneration. Reducing oxidative stress and resultant inflammation may help in reducing the
risk of ERM formation. Since ILM peeling also has detrimental role on the retina, these findings not
only expand our knowledge about ERM pathogenesis but are helpful in identifying newer potential
therapies to clinically manage blinding diseases like RD and PDR.
Further investigations on role of microglia and immunomodulation of its phenotype are underway
to expand our understanding of its role in DR pathogenesis and better management of this disease and
related retinopathies.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-3921/9/8/654/s1,
Table S1: List of antibodies, Table S2: List of qPCR primers, Figure S1: Representative images of ERMs after
H&E at 40X showing the glial cells with clear spindle shaped structure of the cells and their long thin processes.
Macrophages were also seen with round darkly stained structure. Pigmentation was also observed in the
membranes. Figure S2: Characterization of Müller glia cells using AldH1L1 (a specific marker for Müller glia) in
MH, iERM, PDR and RD membranes.
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